DEXCOM INC. DL-,001/ US2521311074 /
24/05/2024 08:00:11 | Chg. -5.30 | Volume | Bid21:59:58 | Ask21:59:58 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
115.86EUR | -4.37% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 46.83 bill.EUR | - | - |
GlobeNewswire
08/04
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
31/01
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.